Winners and Losers: Pharma giant rallies on new appointment
The state’s top pharmaceuticals company enjoyed investor attention this week after naming a US bigwig to its board.
Mayne Pharma was one of South Australia’s biggest share market Winners of last week, rising on the back of the company naming a new board member.
The company, based in Salisbury, announced Meghan Rivera had joined the board of Mayne Pharma.
Rivera, a US resident, has more than 25 years of experience in the US pharmaceuticals industry and was currently vice president and global commercial lead for ViiV Healthcare – a leading biopharmaceutical organisation focused on prevention, treatment and cure of HIV.
Mayne Pharma chair Professor Bruce Robinson said Rivera was an “experienced executive with a wealth of US pharma experience”.
It was Spacetalk, however, that topped the Winners list last week – the last full week of trading for the FY26 financial year.
Other winners included Terramin Australia, Prophecy International and Fortifai. The latter was up a whopping 1205.88 per cent over the past year.
The broader market was down, particularly mid, small and micro cap companies – the Emerging Markets Index falling 4 per cent.
Stay informed, daily
While a rising US dollar impacted technology and resource stocks, Brent Oil prices fell 8 per cent this week.
The full list of Winners and Losers for the week ended June 26:
Want to see more stories from InDaily SA in your Google search results?
- Click here to set InDaily SA as a preferred source.
- Tick the box next to "InDaily SA". That's it.
